Michael Ehlers is an accomplished scientist, biotech entrepreneur, and R&D leader with a vast experience in the biotechnology and pharmaceutical industries. He holds degrees in both medicine and neuroscience from the Johns Hopkins University School of Medicine, where he studied MD, PhD. Michael has a demonstrated history of innovation, organizational leadership, and therapeutic development, with a particular emphasis on neuroscience.

Michael has held several leadership positions during his illustrious career, including Chief Scientific Officer and Venture Partner at Apple Tree Partners, President & Executive Chair at Aulos Bioscience, Chief Executive Officer at Limelight Bio & Affiliates, Group Senior Vice President, BioTherapeutics at Pfizer, Executive Vice President at Biogen, and Senior Vice President, Chief Scientific Officer for Neuroscience at Pfizer. Before joining the pharmaceutical industry, Michael was a Professor of Neurobiology at Duke University.

As a renowned scientist and biotech entrepreneur, Michael Ehlers has made significant contributions to neuroscience research and therapeutic development. His work has led to the development of groundbreaking treatments and therapies for neurodegenerative diseases, such as Alzheimer's and Parkinson's.